Robocath has announced that that the well-known interventional cardiologists Michael Haude, Faziel Lorgat, and Holger Nef have joined its medical advisory board. Founded in 2009 by Philippe Bencteux, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases; this includes R-One, which is designed to optimise the safety of robotic-assisted coronary angioplasty.
A press release reports that the board plays a key role in defining the clinical strategy of the company. Their clinical work will contribute to the worldwide growth of robotics in interventional cardiology.
The new appointees:
- Michael Haude (Städtische Kliniken Neuss, Neuss, Germany) has been head of the cardiac catheterization laboratory at Neuss Clinic for the last 25 years, is a past chairman of the Working Group on Interventional Cardiology (AGIK) at the German Society of Cardiology, is a PCR and ESC board member and was EAPCI president from 2016 to 2018. He has published more than 300 scientific articles.
- Faizel Lorgat (Netcare Christiaan Barnard Memorial Hospital, Cape Town, South Africa) has been an interventional cardiologist at Christiaan Barnard Memorial Hospital since 1998. One of the first users of a robotic system for electrophysiology, Lorgat has performed more than 1,600 procedures with this robotic assistance over a period of six years and is an active research contributor in this field.
- Holger Nef (Giessen University Hospital, Giessen, Germany) has been head of the cardiac catheterisation laboratory at Giessen University Hospital for the last 10 years. He is director of the department for structural heart disease at the Herz-Kreislauf-Zentrum, Rotenburg, Germany, has been president of the Working Group on Interventional Cardiology (AGIK) at the German Society of Cardiology since 2015, and is the author of numerous scientific publications and plays an active role in professional education.
These three experts join Robocath’s existing board members: Alberto Cremonesi (Humanitas Gavazzeni Hospital, Bergamo BG, Italy), Alain Cribier (Emeritus Professor and TAVI founder, Rouen University Hospital, Rouen, France), Jean Fajadet (Pasteur Clinic, Toulouse, France), Eric Durand (Rouen University Hospital, Rouen, France), Rémi Sabatier (Caen University Hospital, Caen, France), Gregg Stone (Columbia University Hospital, New York, USA).
Philippe Bencteux, president and founder of Robocath, says: “I am particularly proud and pleased to welcome Michael Haude, Faizel Lorgat and Holger Nef to our medical advisory board. As experts they have demonstrated their strong commitment and enthusiasm to being part of this new page in history. We all share the same vision regarding the future of interventional cardiology and the key role that our robotic platform will play in this field.”